Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. (Q44421351)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Roberto Garcia-Navarrete

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Esperanza Garcia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Patricia Guevara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Rodolfo Ondarza

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Daniel Rembao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Julio Sotelo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

3210-3218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115353%20AND%20SRC:MED&resulttype=core&format=json

The trends in incidence of primary brain tumors in the population of Rochester, Minnesota.

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Angiogenesis in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Hepatocyte growth factor: a multifunctional cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

HGF: a multifunctional growth factor controlling cell scattering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Expression of c-met is a strong independent prognostic factor in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Targeting angiogenesis: genetic intervention which strikes at the weak link of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Expression of scatter factor in human bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Hepatocyte growth factor/scatter factor-induced intracellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Peritumoral brain edema in meningiomas--influence of vascular supply on its development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Immunohistochemical examination of c-Met protein expression in astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Depressed T lymphocyte function in brain tumor patients: Monocytes as suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Necrosis as a prognostic factor in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Brain tumors in Mexico: characteristics and prognosis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Tumor angiogenesis--a new therapeutic target in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Fractionated radiation therapy in the treatment of intracranial meningiomas: local control, functional efficacy, and tolerance in 91 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Efficacy of conventional radiotherapy for recurrent meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Hepatocyte growth factor/scatter factor in the eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Biological role of HGF/MET pathway in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Recurrence of meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

MIB-1 staining index of pediatric meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594

Different point mutations in the met oncogene elicit distinct biological properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10594